Frontiers in Radiology (Dec 2023)

Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration

  • Francesco Sanvito,
  • Francesco Sanvito,
  • Timothy J. Kaufmann,
  • Timothy F. Cloughesy,
  • Timothy F. Cloughesy,
  • Patrick Y. Wen,
  • Benjamin M. Ellingson,
  • Benjamin M. Ellingson,
  • Benjamin M. Ellingson,
  • Benjamin M. Ellingson,
  • Benjamin M. Ellingson

DOI
https://doi.org/10.3389/fradi.2023.1267615
Journal volume & issue
Vol. 3

Abstract

Read online

Standardized MRI acquisition protocols are crucial for reducing the measurement and interpretation variability associated with response assessment in brain tumor clinical trials. The main challenge is that standardized protocols should ensure high image quality while maximizing the number of institutions meeting the acquisition requirements. In recent years, extensive effort has been made by consensus groups to propose different “ideal” and “minimum requirements” brain tumor imaging protocols (BTIPs) for gliomas, brain metastases (BM), and primary central nervous system lymphomas (PCSNL). In clinical practice, BTIPs for clinical trials can be easily integrated with additional MRI sequences that may be desired for clinical patient management at individual sites. In this review, we summarize the general concepts behind the choice and timing of sequences included in the current recommended BTIPs, we provide a comparative overview, and discuss tips and caveats to integrate additional clinical or research sequences while preserving the recommended BTIPs. Finally, we also reflect on potential future directions for brain tumor imaging in clinical trials.

Keywords